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Introduction: Hepatitis C disease burden is substantially increasing in Egyptian community, it is
estimated that prevalence of Hepatitis C virus (HCV) in Egyptian community reach 22% of total
population. Recently there is a global alert of HCV cardiovascular complications.
Objective: To evaluate LV diastolic functions of HCV patients using tissue Doppler Imaging and
NTPBNP.
Methods: 30 HCV patients of 30 years, sex & BMI matched controls were evaluated by PCR,
ECG, Echocardiography ‘‘conventional Doppler, pulsed wave tissue Doppler (PW-TD), strain rate
imaging’’ & NTPBNP to assess LV diastolic functions. Mean age was 32.8 years ± 5.1 in HCV
group, 29.8 years ± 6.6 in control group. Cardiovascular anomalies and predisposing factors were
excluded.
Results: HCV group has shown signiﬁcant increase in QTc interval, signiﬁcant statistical increase
in A wave, deceleration time; (p< 0.05), highly signiﬁcant decrease in tissue Doppler Ea
(p< 0.001), highly signiﬁcant decrease in Aa (p< 0.001), highly signiﬁcant increased E/Ea ratio
(p value < 0.001), signiﬁcant decrease in Ea/Aa ratio and signiﬁcant increase in SRa (p< 0.05).105642866.
om (A. Saleh).
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Figu
218 A. Saleh et al.NTPBNP levels showed highly signiﬁcant increase with mean value 222 pg/ml ± 283 in HCV group
and 32.7 pg/ml ± 21.2 in control group (p value < 0.001). The best cut-off value of NTPBNP to
detect diastolic dysfunction in HCV group was 213 pg/ml.
No statistical differences in SRe/SRa and E/SRe ratios were observed, however they had signiﬁcant
correlation with NTPBNP level and tissue Doppler parameters. The best cut-off value of E/SRe
ratio to detect diastolic dysfunction in HCV group was 0.91, with 75% sensitivity and 100% spec-
iﬁcity.
Conclusion and recommendation: This data show the ﬁrst direct evidence that HCV infection causes
diastolic dysfunction without any other predisposing factors, probably due to chronic inﬂammatory
reaction with mild ﬁbrosis in the heart. Previous studies did not follow strict inclusion and exclusion
criteria that conﬁrm the independent role of HCV to cause diastolic dysfunction. Tissue Doppler
was more sensitive to diagnose diastolic dysfunction than conventional Doppler.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Hepatitis C virus (HCV) is the cause of many different forms
of heart diseases worldwide. Up till now, few cardiologists
are aware of (HCV) as an etiology of heart disease and its
treatment. HCV infection is seen globally, and is often unde-
tected and therefore untreated. The burden of HCV-derived
heart diseases is global, with higher prevalence in Asia, Africa,
and low- and middle-income countries. Egypt has the highest
prevalence of HCV in the world, apparently due to previous
mass parenteral anti-schistosomal therapy (Defﬁc-Burban
et al., 2006). HCV derived heart diseases are chronic, persis-
tent, and devastating diseases (Matsumori et al., 2006).
The myocardium may be the target of several types of viral
infections. Recently, the importance of hepatitis C virus
(HCV) infection has been noted in patients with hypertrophic
cardiomyopathy, dilated cardiomyopathy, myocarditis and left
ventricular (LV) diastolic dysfunction (Raedle-Hurst et al.,
2008; Henriksen and Møller, 2009).
Because of its high reproducibility, feasibility, and rela-
tively preload-independence, tissue Doppler recording of
the early diastolic mitral annular velocity (Ea) in conjunction
with the mitral inﬂow velocity (E) has become the ﬁrst line
of diastolic evaluation. Myocardial relaxation is impaired in
almost all patients with diastolic dysfunction, which is best
assessed by the Ea velocity of the mitral annulus using tissue
Doppler imaging (TDI). While early diastolic trans-mitral
velocity (E) increases progressively as LV ﬁlling pressure in-
creases, the mitral annular Ea velocity remains decreased at
all stages of diastolic dysfunction (Thomas and Marwick,
2007).
Other recent tool is demonstrated to assess LVdiastolic func-
tion which is strain and strain rate imaging, Strain, in daily lan-re 1 ECG of HCV infected paguage means, ‘‘stretching’’. In scientiﬁc usage, the deﬁnition is
extended to mean ‘‘deformation’’ (Asbjørn Støylen, 2005).
Extending the utility of BNP as a diagnostic marker to
screen for asymptomatic or preclinical ventricular dysfunction
according to the ACC/AHA guidelines (Hunt et al., 2005) in
the general population has not proved cost-effective as the
prevalence of heart failure is low. However, if the test is used
in patients stratiﬁed for risk using clinical criteria, BNP has
proved useful to ‘‘rule out’’ ventricular dysfunction, thus
eliminating the need for other more expensive diagnostic tests
in this group (Yamamoto et al., 2000).
Of all investigated neurohormones and natriuretic peptides,
B type natriuretic peptide and N-terminal proBNP are the best
markers for ruling out left ventricular dysfunction and to de-
tect the degree of severity (Hammerer-Lercher et al., 2004;
Park et al., 2010).2. Aim of work
The aim of this study is to evaluate the cardiac involvement of
HCV using tissue Doppler imaging ‘‘TDI’’ combined with
NTproBNP. Any factor that can lead to cardiac insult will
be excluded in order to clearly identify HCV cardiotropism.3. Methods
3.1. Participants
This study included 60 adult patients. Patients were enrolled in
two groups with body mass index, age and sex matched.
Group one included thirty patients below 40 years old
infected with hepatitis C virus (HCV) while group twotient showing long QTc interval.
Figure 2 Pulsed wave tissue Doppler of a patient from HCV
group, ﬁgure shows reversed Ea/Aa ratio.
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infection.
HCV group included 18 male patients and 12 female
patients control group included 14 males and 16 females.
Patients with systolic dysfunction ‘‘Ejection Fraction (EF)
less than 50%’’, congenital heart disease or valvular heart
disease, restrictive cardiomyopathy, hypertrophic cardio-
myopathy, pericardial constriction or myocarditis were
excluded.Figure 3 Strain rate imaging data of one of HCV pPatients with diabetes mellitus, hypertensive, smokers or
those over 40 years of age, BMI below 18.5 kg/m2 or over
30 kg/m2 and patients with history of treatment with interferon
were also excluded.
Plasma sample was taken from every patient to analyze
the level of N-Terminal pro Brain Natruretic Peptide
(NTproBNP). Blood sample was obtained and 1 ml refriger-
ated EDTA plasma (lavender-top tube); was gone through
immuno (electro) chemiluminescence assay (ICMA) in Roche
Elecsys 2010 bench top analyzer.
3.2. Echocardiographic acquisition and analysis
Each patient had a complete two-dimensional echocardiogra-
phy study using a commercially available ultrasound scanner
(Vivid 7, General Electric Medical Health) with a 2.5-MHz
phased-array transducer. Standard echocardiographic views,
including apical four- and two-chamber views, with the patient
in the left lateral decubitus position, Mitral inﬂow velocities
were obtained by pulsed wave Doppler in the apical four-
chamber view with a 1- to 2-mm sample volume placed at
the tips of the mitral valve leaﬂets during quiet respiration.
Mitral E and A wave velocities (cm/s) and deceleration time
(milliseconds) were measured ofﬂine and averaged over two
or three cardiac cycles. The E/A ratios were calculated.
3.3. Doppler tissue imaging
Pulsed wave Doppler tissue imaging velocities were obtained
from the apical four-chamber view during quiet respirationatients, reversed SRe/SRa ratio can be observed.
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Cursor line was more aligned with examined wall (15–20) to
decrease incidence of angle error. The peak early diastolic
mitral annular velocities (Ea, cm/s) and peak late diastolic
mitral annular velocities (Aa, cm/s) were measured from the
time-myocardial velocity waveforms of 2–3 consecutive
cardiac cycles and an average were recorded. The lateral
E/Ea ratio, a measure of LV ﬁlling pressure, was calculated.Figure 4 Direct relationship between NTPBNP and corrected
QT interval where r= 0.334 and p value = 0.009.3.4. Strain rate imaging
Doppler tissue imaging recordings were taken at 134 ± 22
frames/s in the apical four-chamber view. Analysis was
independently and separately performed on a commercially
available analysis computer (Echopac, GE Systems) by two
cardiologists blinded to the categorization of participants.
Peak early diastolic strain rate (SRe) and peak late diastolic
strain rate (SRa) measurements for three consecutive cardiac
cycles were averaged for each participant. For longitudinal
measurements, samples were placed at the basal, mid, and
apical septal and lateral walls in the apical four-chamber view
then Strain rate data were averaged. Participants were
excluded from the study if the axis of the septum deviated from
the line of the Doppler beam by more than 15–20.
Echocardiograms of 20 participants were randomly selected
and repeated measurements of E, A, and Ea, Aa, SRe and SRa
were blindly performed after initial evaluation to assess intra-
observer variability.Figure 5 Direct relationship between NTPBNP and E/Ea ratio,
r= 0.619 and p value <0.001.3.5. Statistical analysis
Data were analyzed using Statistical Package for Special
Science (SPSS) software computer program version 15. Data
were described as mean ± standard deviation (SD) for quanti-
tative (numerical) variables and as frequency & percentage for
qualitative (categorical) variables. Independent student t test
was used for comparison of quantitative variables among two
independent groups. Chi-square test (or Fisher’s exact test when
appropriate) was used for comparison of distribution of quali-
tative variables among different groups. Correlation between
continuous variables was performed using person correlation
coefﬁcient. Signiﬁcance level (P) value:*P> 0.05 is insigniﬁ-
cant. *P 6 0.05 is signiﬁcant. *P< 0.001 is highly signiﬁcant.Figure 6 Direct relationship between NTPBNP and quantitative
PCR, r= 0.515 and p= 0.004.4. Results
A signiﬁcant statistical increase was observed in QT corrected
interval of resting ECG in HCV patients, compared to normal
control group, p value < 0.05 ‘‘Fig. 1’’. Incidence of prolonged
QTc interval was 10% in HCV group. There was a highly sig-
niﬁcant statistical increase in plasma levels of NTproBNP in
HCV group, p value <0.001.There was no statistical difference
in HCV patients and normal control group concerning systolic
function as assessed by EF measured fromM-mode, Simpson’s
method, p= 0.097 or tissue Doppler ‘‘Sa’’ wave where it was,
p= 0.63 (Table 1).
There was a signiﬁcant statistical increase in A wave veloc-
ity in HCV patients and signiﬁcant increase in deceleration
time ‘‘DT’’, p value <0.05. A highly signiﬁcant decrease in
Ea wave was observed in HCV patients, p value <0.001
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HCV patients, p value <0.001 ‘‘Fig. 2’’. Pulsed wave tissue
Doppler Ea/Aa ratio showed signiﬁcant decrease of Imaging
in HCV patients, p value <0.05. Incidence of reversed Ea/Aa
ratio was 26.7% in HCV group. There was a highly signiﬁcant
statistical increase in E/Ea ratio in HCV patients, p value
<0.001. Those tissue Doppler parameters ‘‘Ea, Aa, Ea/Aa
and E/Ea’’ clearly indicate diastolic dysfunction in HCV
patients (Table 1).
There was no statistical difference between HCV patients
and normal control group concerning SRe ‘‘early diastolic rate
of deformation wave of strain rate imaging’’ or SRe/SRa ratio.
However, there was a signiﬁcant increase in SRa ‘‘late diastolicTable 1 Baseline and Echocardiographic characteristics of HCV gr
Group
Age HCV group
Control group
Heart rate HCV group
Control group
Arterial blood pressure ‘‘systolic’’ HCV group
Control group
Arterial blood pressure ‘‘diastolic’’ HCV group
Control group
Body mass index HCV group
Control group
NTproBNP HCV group
Control group
QTc HCV group
Control group
EF HCV group
Control group
Doppler E wave HCV group
Control group
Doppler A wave HCV group
Control group
E/A ratio HCV group
Control group
Deceleration time HCV group
Control group
Vp HCV group
Control group
Sa wave HCV group
Control group
Ea wave HCV group
Control group
Aa wave HCV group
Control group
Ea/Aa ratio HCV group
Control group
E/Ea ratio HCV group
Control group
SRe wave HCV group
Control group
SRa wave HCV group
Control group
SRe/SRa ratio HCV group
Control group
E/SRe ratio HCV group
Control group
Table of mean values, std. deviation and p values of research parameters
pro Brain Natriuretic Peptide, QTc: corrected QT interval, EF: Ejection
systolic velocity, Ea: tissue Doppler mitral early diastolic velocity, Aa: tissu
deformation and SRa: late diastolic rate of deformation.rate of deformation wave of strain rate imaging’’, p value
<0.05 ‘‘Fig. 3’’.
Levels of NTproBNP had shown the following correlations:
‘‘Figs. 4–6’’.
Strong inverse correlation with Ea/Aa ratio, r-value =
‘‘0.777’’, p value <0.001, average direct correlation with
E/Ea ratio, r-value = ‘‘0.619’’, p value <0.001, average direct
correlation with PCR, r-value = ‘‘0.515’’, p value =0.004,
average direct correlation with deceleration time, r-value =
‘‘0.541’’, p value <0.001 and had weak direct correlation
with QTc interval, r-value = ‘‘0.334’’, p value = 0.009. Hower-
er, no correlation was found between NTproBNP level with
SRa.oup and Control group.
Mean value Std. deviation ± P value
32.8 5.1 0.06
29.8 6.6
81.20 10.390 0.6762
79.50 8.935
121.68 9.013 0.8576
120.55 10.736
76.00 9.0676 0.7025
77.50 8.8976
25.8 1.85 0.619
25.6 1.86
222.252 283.444 >0.001
32.688 21.234
373.571 49.156 0.048
350.666 36.759
62.38 8.25 0.097
65.15 7.67
0.852 0.207 0.512
0.821 0.152
0.726 0.228 0.009
0.598 0.121
1.278 0.450 0.220
1.390 0.198
217.733 45.521 0.002
184.633 31.469
73.466 32.722 0.145
83.933 20.844
9.17 1.79 0.63
9.39 1.48
0.106 0.040 >0.001
0.260 0.117
0.108 0.039 >0.001
0.240 0.130
1.153 0.557 0.002
1.512 0.238
9.108 3.517 >0.001
3.353 2.174
2.066 1.347 0.6
1.927 0.506
1.360 0.621 0.035
1.079 0.346
1.694 1.134 0.435
1.885 0.690
0.614 0.455 0.098
0.463 0.175
between HCV patients and control group. NTproBNP: N-Terminal
Fraction, Vp: ﬂow propogation velocity, Sa: tissue Doppler mitral
e Doppler mitral late diastolic velocity, SRe: early LV diastolic rate of
222 A. Saleh et al.5. Discussion
Our results came compatible with Dimerdal study in which the
number of subjects with diastolic dysfunction in the study
group (n= 18) were signiﬁcantly higher than the control
group (n= 4) (p< 0.05). This agrees with the results of our
study, although none of our control group has shown diastolic
dysfunction. That difference might be due to including older
age group in his study (Demirdal et al., 2007).
Raedle-Hurst et al. has evaluated HCV patients using tis-
sue Doppler and NTPBNP, a cutoff value of greater than
290 pg/ml was highly predictive of advanced left ventricular
diastolic dysfunction in this study with signiﬁcant difference
in tissue Doppler indices between HCV group and normal
control. Ea wave was signiﬁcantly decreased while Aa wave
was signiﬁcantly increased. Ea/Aa ratio was signiﬁcantly de-
creased. This study agrees with our study tissue Doppler
parameters and increased levels of NTPBNP (Raedle-Hurst
et al., 2008).
A previous Egyptian study was made to assess the cardio-
vascular effect of HCV on Egyptian patients and had found
signiﬁcant decrease in Doppler E wave, signiﬁcant increase in
A wave, signiﬁcant decrease in E/A ratio, signiﬁcant increase
in LV wall thickness ‘‘septal & posterior’’ and signiﬁcant
prolongation of corrected QT interval. This study agrees with
our results in ﬁnding signiﬁcant prolongation in QTc interval
and in signiﬁcance of increased Doppler A wave velocity.
While it contradict our results where we found no statistical
difference between HCV group and normal control group con-
cerning Doppler E wave velocity, E/A ratio and LV septal &
posterior wall thickness (Haykal and Negm, 2009).
Another Japanese study aimed to determine the prevalence
of hepatitis C virus (HCV) infection and myocardial injury
among patients enrolled in the Myocarditis Treatment Trial.
Anti-HCV antibodies were identiﬁable in sera and were more
prevalent in patients with myocarditis and HF than in the gen-
eral population. The study concluded that NTPBNP is a more
sensitive marker of myocardial injury than cardiac troponins
in patients with heart failure from HCV myocarditis. This
agrees with our study where we found high signiﬁcant increase
in NTPBNP levels in HCV group compared to normal control
group (Matsumori et al., 2006).
Antonelli et al. evaluated serum levels of NTproBNP in a
large series of patients with HCV chronic infection (HCV+).
Serum NTproBNP was assayed in 50 patients HCV+ and in
50 sex- and age-matched controls. HCV+ patients showed sig-
niﬁcantly higher mean NTproBNP level than controls
(P= 0.001). By deﬁning high NTproBNP level as a value
higher than 125 pg/mL (the single cut-off point for patients un-
der 75 years of age), 34% HCV+ and 6% controls had high
NTproBNP (Fisher exact test; P< 0.001). With a cut-off
point of 300 pg/mL (used to rule out chronic heart failure in
patients under 75 years of age) 10% HCV+ and 0 controls
had high NTproBNP (Fisher exact test; P= 0.056). With a
cut-off point of 900 pg/mL (used for ruling in chronic heart
failure in patients with age 50–75) 8% HCV+ patients and 0
controls had high NTproBNP (Fisher exact test; P= 0.12).
The study demonstrates high levels of circulating NTproBNP
in HCV+ patients compared to healthy controls. The increase
of NTproBNP may indicate the presence of a sub-clinical car-
diac dysfunction (Antonelli et al., 2010).A study by Dimitroulas et al. evaluated 52 patients with
Systemic Sclerosis ‘‘SSc’’ (mean age 55.7 +/ 10.1 years,
51 women), with conventional and tissue Doppler echocardi-
ography. Plasma NTproBNP levels were measured in all pa-
tients. Data were compared with those obtained from 25
healthy controls comparable for age and sex. Patients with
SSc had impaired left ventricular and right ventricular
diastolic function expressed by inverted ratio of peak early
to peak late transmittal (E/A) ratio and trans-tricuspid veloc-
ity and increased left atrial diameter compared with controls.
Peak systolic mitral lateral annular motion velocity and peak
early diastolic mitral lateral annular motion velocity (LV Ea)
were lower, while LV E/Ea ratio was higher, in patients with
SSc compared to controls. NTproBNP was associated with E,
E/A ratio and mitral deceleration time. NTproBNP was
signiﬁcantly correlated with echocardiographic abnormalities,
providing a potent link for cardiac function and neuroendo-
crine derangement in patients with SSc who have cardiac
disease (Dimitroulas et al., 2010).6. Study limitations
Limitations of this study were either linked to the usual limita-
tions of tissue Doppler imaging or linked to evaluation of
HCV patients. Limitations related to TDI included its inability
to discriminate between active and passive motion due to teth-
ering or overall cardiac rotational/translational motion. It is
also inﬂuenced by breathing, patient motion, heart rate varia-
tions and it is angle-dependent. Limitations linked to evalua-
tion of HCV patients were including relatively small number
of patients, evaluating HCV genotype 4 which is found in
Egypt and Africa while sparing the other genotypes which
are more prevalent in Asia and South America. We did not
link the length of infection to the abnormalities of cardiac con-
dition due to the accidental nature of discovering the infection
of HCV in Egypt (Table 1).7. Conclusion
1. Tissue Doppler was more sensitive to diagnose diastolic
dysfunction than conventional Doppler.
2. NTproBNP is a strong indicator of diastolic dysfunction in
HCV patients and is directly related to echocardiographic
parameters in addition to the level of viraemia hence we
recommend its routine use as a follow up tool in HCV
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